Discovery, Inc. Series B Common Stock
DISCB
DISCB was delisted on the 8th of April, 2022.
8 hedge funds and large institutions have $3.03M invested in Discovery, Inc. Series B Common Stock in 2014 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
8% less capital invested
Capital invested by funds: $3.31M → $3.03M (-$281K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$3.52K |
| 2 |
Morgan Stanley
New York
|
+$586 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
-$12.2K |
| 2 |
JFGIW
Johnson Financial Group Inc (Wisconsin)
Racine,
Wisconsin
|
-$9K |
DISCB Hedge Fund Activity: Q1 2014 in Review
8 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Discovery, Inc. Series B Common Stock (DISCB) for Q1 2014, worth a combined $3.03M — down 8.5% from $3.31M a quarter earlier.
Fund positioning in DISCB was balanced in Q1 2014: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $3.52K. The largest seller was UBS, cutting an estimated $12.2K.
- 8 institutional investors held Discovery, Inc. Series B Common Stock (DISCB) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $3.03M of Discovery, Inc. Series B Common Stock stock for Q1 2014, down 8.5% quarter-over-quarter.
- 1 fund opened new Discovery, Inc. Series B Common Stock positions in Q1 2014 and 1 closed out, a net change of 0 holders.
- The largest Discovery, Inc. Series B Common Stock buyer in Q1 2014 was Invesco, an estimated $3.52K added.
- The largest Discovery, Inc. Series B Common Stock seller in Q1 2014 was UBS, an estimated $12.2K sold.
Based on aggregated 13F filings for Q1 2014.